The announcement was made Oct. 30 by Maj. Gen. Cedric Wins, commanding general of the U.S. Army Research, Development and Engineering Command, ECBC’s higher headquarters. Moore served as ECBC’s research and technology director from August 2016 to May 2017.

“It’s a tremendous honor to be selected to lead our world-class team of scientific, engineering, and support professionals at ECBC,” Moore said. “Together, we’ll continue to ensure that U.S. and allied Warfighters have the right chemical and biological defense solutions to be operationally ready to fight and win in any environment.”

Moore has a distinguished career in the Department of Defense’s Chemical and Biological Defense Program. From 2007 through 2016, Moore served in various roles at the Defense Threat Reduction Agency (DTRA) including as chief of the Advanced and Emerging Threat Division in DTRA’s Chemical and Biological Technologies Department.

Moore graduated from Fisk University in Nashville, Tennessee, where he was an ROTC cadet, with a bachelor’s degree in biology. Upon graduation, Moore accepted a commission as a second lieutenant in the Army Medical Service Corps where he supported the Chemical and Biological Defense Program in various roles, including serving at U.S. Army Medical Research Institute of Chemical Defense.

Moore went on to earn a doctorate in neurophysiology from Meharry Medical College in Nashville. His other Army assignments sent him to the Armed Forces Medical Intelligence Center as the Defense Intelligence Agency’s senior scientific and technical intelligence officer for chemical, biological, radiological, and nuclear medical countermeasures worldwide, and to the U.S. Army Forensic Toxicology Drug Testing Laboratory, Fort Meade, Md. where he served as commander and lab director.